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AbstrACt
Introduction Communicable diseases are the leading 
causes of death in Tanzania despite the existence 
of effective treatment tools. We aimed to assess the 
sociocultural and health system factors associated with 
mortality from febrile illness in northern Tanzania.
Methods We interviewed febrile inpatients to determine 
prevalence of barriers in seeking or receiving care and 
grouped these barriers using the Three Delays model 
(delays at home, in transport and at healthcare facilities). 
We assessed 6-week mortality and, after matching on age, 
gender and severity of illness, measured the association 
between delays and mortality using conditional logistic 
regression.
results We enrolled 475 children, of whom 18 (3.8%) 
died, and 260 adults, of whom 34 (13.0%) died. 
For children, home delays were not associated with 
mortality. Among adults, a delay in care-seeking due to 
not recognising severe symptoms was associated with 
mortality (OR: 3.01; 95% CI 1.24 to 7.32). For transport 
delays, taking >1 hour to reach a facility increased odds 
of death in children (OR: 3.27; 95% CI 1.11 to 9.66) and 
adults (OR: 3.03; 95% CI 1.32 to 6.99). For health system 
delays, each additional facility visited was associated with 
mortality for children (OR: 1.59; 95% CI 1.06 to 2.38) and 
adults (OR: 2.00; 95% CI 1.17 to 3.41), as was spending 
>4 days between the first facility visit and reaching tertiary 
care (OR: 4.39; 95% CI 1.49 to 12.93).
Conclusion Our findings suggest that delays at home, in 
transport and in accessing tertiary care are risk factors 
for mortality from febrile illness in northern Tanzania. 
Interventions that may reduce mortality include community 
education regarding severe symptoms, expanding 
transportation infrastructure and streamlining referrals to 
tertiary care for the sickest patients.
IntroduCtIon
Fever is common in low-resource areas, with a 
2-week period prevalence as high as 27%.1 In 
Tanzania, common aetiologies among febrile 
inpatients include bloodstream infections and 
bacterial zoonoses,2 and febrile illnesses are 
still major causes of death3 4 despite the exist-
ence of effective treatment tools such as anti-
microbials and clinical management guide-
lines.5 As such, sociocultural, behavioural and 
health system factors6–8 may contribute to 
mortality from infectious diseases.
Social autopsy has been used to describe 
non-biological contributors to fatal infections, 
Key questions
What is already known about this topic?
 ► Social autopsy is a retrospective interview tool that 
has been used successfully to assess sociocultural 
and health systems barriers to care in febrile 
illness.
 ► Social autopsy is limited, however, by its 
retrospective approach and lack of control group.
What are the new findings?
 ► Ours is the first study to our knowledge to use the 
social autopsy framework in a prospective cohort 
study and to determine which sociocultural and 
health system factors are associated with mortality.
 ► We found that delays in care-seeking, delays in 
transport and spending more time between initial 
presentation to a health facility and reaching 
tertiary level care were all associated with an 
increased odds of mortality.
recommendations for policy
 ► Our results suggest that there are social and 
health system factors associated with mortality 
from febrile illness, which may help explain why 
communicable diseases are still the leading causes 
of death in Tanzania.
 ► Interventions to improve severe illness recognition 
in the community, shorten transport times and 
expedite referrals to tertiary care when necessary 
may help prevent deaths from febrile illness in 
northern Tanzania.
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including malaria in Tanzania9 and febrile illness and 
pneumonia in Uganda.10 11 Administered as a structured 
interview to family members following a person’s death, 
social autopsy solicits information on healthcare-seeking, 
sociocultural barriers to care and barriers within the 
healthcare system.12 13 Identification of delays through 
social autopsy can provide evidence to inform interven-
tions. For example, a social autopsy study in Niger found 
that transport was the main barrier to effective perinatal 
care, and the government responded by making motor-
cycle ambulances available for mothers in labour.14
Standard retrospective social autopsy is limited by 
substantial recall15 16 and selection17 bias. In addition, 
without non-fatal controls, social autopsy studies have 
been unable to conclude whether non-biological factors 
are truly associated with increased odds of mortality. 
Furthermore, few social autopsy studies have enrolled 
non-maternal adults. In our study, we adapted social 
autopsy for a prospective cohort study of febrile inpa-
tients of all ages. Since our tool is used during life, it is 
best described as a ‘social biopsy’. Our objective was to 
determine the sociocultural barriers, healthcare-seeking 
behaviour and health system factors that are associated 
with mortality from febrile illness in northern Tanzania.
MetHods
study area and population
We enrolled participants at two hospitals in Moshi, 
Tanzania, the administrative capital of the Kilimanjaro 
Region. Mawenzi Regional Referral Hospital (MRRH) 
serves as the region’s tertiary referral hospital with 300 
beds. Kilimanjaro Christian Medical Centre (KCMC) is 
one of four consultant tertiary hospitals in Tanzania and 
has 458 beds, serving a catchment population of more than 
10 million people, including people served by MRRH.
Study team members screened all patients admitted to 
paediatric and adult medical wards at MRRH and KCMC 
from June 2015 to June 2016. Patients were screened as 
soon as possible and no later than 48 hours after admis-
sion. Patients with a history of fever in the past 72 hours; 
tympanic, rectal or oral temperature of ≥38.0°C at admis-
sion; or axillary temperature of >37.5°C at admission 
were eligible to participate in the study.
data collection
After obtaining informed consent from the patient or 
guardian, trained clinical officers administered a struc-
tured interview in Kiswahili. We designed our question-
naire based on the International Network for the Demo-
graphic Evaluation of Populations and Their Health 
standardised social autopsy tools for child and maternal 
death12 and the Child Health Epidemiology Reference 
Group social autopsy questionnaire.13 Our questionnaire 
captured information on participant demographics, soci-
oeconomic characteristics and barriers to care. We also 
asked about the presence of severe symptoms that should 
prompt immediate referral to a hospital, as defined by 
the World Health Organization Integrated Management 
of Childhood Illness (IMCI) and Integrated Management 
of Adolescent and Adult Illness (IMAI) guidelines.18 19 We 
telephoned participants to assess their vital status within 
6 weeks of enrolment in the study.
We defined cases as participants who died within 6 weeks 
of enrolment and controls as those who were alive at the 
time of follow-up between 3 and 6 weeks after enrolment. 
Mirroring the age threshold used at MRRH and KCMC, we 
defined paediatric participants as those under 13 years of 
age and adults as those 13 years and older. For analysis of 
IMCI severe symptoms, we defined infants as participants 
younger than 12 months of age and children as paediatric 
participants 12 months of age or older.
Box 1 List of all 15 barriers to care as used in the severe 
febrile illness social biopsy study, tanzania, 2015–2016, 
categorised by home, transport and health system delays 
according to the three delays model.
Home delays
 ► Patient reported delay in seeking care due to thinking illness was 
not severe but severe symptom was present.
 ► Patient waited >24 hours to seek care after onset of severe 
symptom.*†
 ► Patient treated at home despite severe symptom.
transport delays
 ► Patient reported a delay due to transport or cost of transport at any 
point.
 ► Patient delayed >1 hour to reach a facility at any point.†‡
Health system delay
 ► Patient did not get referred to a hospital from the first facility after 
onset of severe symptom.
 ► Patient did not take themselves to a hospital after onset of severe 
symptom (ie, did not ‘short-circuit’ referral).
 ► Patient did not receive antibiotics at the first peripheral facility 
after onset of severe symptom.
 ► Patient reported a barrier at a health facility due to discrimination, 
language or physical access.
 ► Patient waited >1 hour to receive medication at any point.*
 ► Patient visited >2 facilities.† §
 ► Patient waited>1 hour to be seen by a provider at any point.*
 ► Patient reported delay due to cost of healthcare.
 ► Patient did not complete a given treatment due to patient or 
caregiver decision.
 ► Patient spent >4 days in the healthcare system.†¶
*This threshold was based on a cut-off value used in the social autopsy 
literature.
†This delay was also analysed as a continuous variable (see Results).
‡Social autopsy literature has used a cut-off of >2 hours, but our participants’ 
average transport time was lower and thus a cut-off of 2 hours was not 
instructive.
§Social autopsy literature has used a cut-off of >1 facility, but since our study 
was hospital based and we were hoping to test whether the WHO Integrated 
Management of Childhood Illness and Adult and Adolescent Illness guidelines 
of a severe symptom prompting referral to a hospital were being followed, we 
set our threshold at >2 facilities.
¶The threshold of >4 days was set post hoc based on our participants’ mean 
number days spent in the healthcare system.
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statistical analysis
We used a matched case–control analysis nested within 
our prospective cohort study to measure the association 
between barriers to care and mortality for paediatric and 
for adult participants, respectively. We assessed 15 barriers 
to care, categorised into delays at home, in transport and 
within the healthcare system based on the Three Delays 
model (box 1).20
Within the paediatric and adult cohorts, respectively, we 
matched cases with controls based on age quintile, gender 
and severity of illness. We matched on age quintile to allow 
for more precise matching on other covariates, and because 
in estimating outcome from infection, the broader age 
group is likely an appropriate predictor.21–23 When analysing 
home and transport delays, we matched only on age and 
gender, as the presence of a severe symptom was implicit in 
home delays, and transport delays were assessed at multiple 
points in time and thus did not have reference points at 
which to measure severity. For healthcare system delays, we 
matched on age, gender and severity of illness at the time 
of the first encounter with a healthcare facility during the 
current illness.
To match on severity of illness, we first determined 
separately for infants, children and adults whether cases 
and controls had similar distributions of IMCI or IMAI 
severe symptoms using the Kolmogorov-Smirnov equal-
ity-of-distributions test. If there was a significant differ-
ence in distributions, we included a severity of illness 
score in the matching algorithm. We generated the 
severity of illness score using principal component anal-
ysis of the IMCI or IMAI severe symptoms present at time 
of study enrolment. Next, we used a logistic regression of 
mortality with the principal components as explanatory 
variables to predict a severity of illness score at the time 
Figure 1 Patients screened, enrolled and reached for follow-up during 1 year of data collection in the severe febrile illness 
social biopsy study, Tanzania, 2015-2016.
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of first encounter with a healthcare facility during the 
current illness.
Our matching algorithm used nearest-neighbour 
matching with replacement and subsequent dedupli-
cation of controls.24 25 If any cases were left without a 
matched control, we reassigned controls such that every 
case was matched with at least one control while main-
taining maximum closeness of matching. We then consol-
idated cases and controls across infants and children to 
make one paediatric cohort. We measured matching 
quality using standardised biases and variance ratios of 
covariates between cases and controls.26 27 The ratio of 
controls to cases was set at a minimum of two but was 
maximised such that the standardised bias remained 
below 10.0% for each covariate.28
We measured the association between each delay and 
6-week mortality using conditional logistic regression. We 
reported results as ORs of mortality with associated popu-
lation attributable fraction (AF). Statistical analysis was 
done using Stata V.14.1. We depicted the differences in the 
sequence and type of facilities visited between cases and 
controls using an adapted Sankey diagram, generated with 
‘The Sankey Diagram Generator’ (Acquire Procurement 
Services, Brisbane, Australia).29 30 We designated private 
clinics and government-run dispensaries and health centres 
as first level facilities. We designated district hospitals as 
secondary level care and regional referral and consultant 
referral hospitals as tertiary care.31–33
To assess the impact of loss to follow-up, we compared 
baseline characteristics between those lost to follow-up and 
those included in the analysis using t-tests for means and χ2 
tests for proportions. To determine whether a participant’s 
clinical presentation was a confounder, we conducted a 
sensitivity analysis in which we repeated the conditional 
logistic regression of mortality for each delay among the 
subset of participants who had each severe symptom.
Patient involvement
A pilot period ensured patient feedback was incorpo-
rated into the questionnaire design. The results of the 
study will be made available to patients through dissemi-
nation to healthcare providers at MRRH and KCMC.
research ethics
Informed consent was obtained from all participants. All 
authors had full access to relevant study data at all times. 
The funding sources had no role in the planning, collec-
tion or analysis of data. We attest that we have obtained 
appropriate permissions and paid any required fees for 
use of copyright protected materials.
resuLts
enrolment
From 23 June 2015 to 30 June 2016, we screened 7092 
inpatient admissions, of whom 1033 (14.6%) were 
enrolled (figure 1). Of those enrolled, 647 (62.6%) were 
paediatric and 386 (37.4%) were adult participants. We 
administered complete questionnaires and obtained 
6-week vital status for 735 (71.2%) participants, of whom 
475 (64.6%) were paediatric and 260 (35.4%) were adult. 
Eighteen (3.8%) paediatric participants and 34 (13.1%) 
adults died.
Participant characteristics
Of 475 paediatric participants, the median age was 1.2 
(IQR 0.6–2.6) years, 205 (43.2%) were female and 237 
(49.9%) participant caregivers had not received educa-
tion beyond primary school (table 1A). Caregivers of 
four (0.8%) participants reported the child being HIV 
seropositive.
Of 260 adult participants, the median age was 38.4 
(IQR 24.1–52.9) years, 119 (45.8%) were female and 166 
(63.8%) had not received education beyond primary 
school (table 1B). Sixty-nine (26.5%) adults were farmers 
by occupation and 42 (16.2%) reported being HIV 
seropositive.
Matched analysis
Both infant and children groups had no differences 
between cases and controls in the distributions of severe 
symptoms (P=0.960 and P=0.980, respectively). Thus, 
matching by severity of illness was not required (online 
supplementary table 1). For adults, there was a differ-
ence in severe symptom distributions between cases and 
controls (P=0.004), and thus adult participants were 
matched on age, gender and, for the analysis of health 
system delays, severity of illness.
three delays
Among 475 paediatric participants, 457 (96.2%) expe-
rienced at least 1 of 15 total delays, and the median 
number of delays per participant was 3 (IQR 2–5). Each 
additional delay present during a paediatric illness 
was associated with increased odds of death (OR: 1.28; 
95% CI 1.03 to 1.59). For adult participants, the median 
number of delays per participant was 3 (IQR 2–5), and 
248 (95.4%) of 260 participants experienced at least one 
delay.
Delays at home
Among paediatric participants, the associations between 
delays at home and mortality were not statistically signif-
icant (table 2). Among adults, a delay in care-seeking 
due to not recognising a severe symptom was associated 
with mortality (OR: 3.01; 95% CI 1.24 to 7.32; AF: 23.6%; 
95% CI 12.4% to 33.3%). Waiting >24 hours to seek care 
after the onset of a severe symptom was also associated 
with increased odds of mortality (OR: 2.50; 95% CI 1.11 
to 5.63; AF: 34.5%; 95% CI 12.8% to 50.8%). Analysed as 
a continuous variable, each additional day between the 
onset of a severe symptom and the first attempt to seek 
care was associated with mortality (OR: 1.21; 95% CI 1.01 
to 1.46). Of the three home delays (box 1), each addi-
tional delay present had an OR of 1.73 (95% CI 1.10 to 
2.71) for mortality.
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Table 1A Background characteristics and prevalence of severe symptoms for 475 paediatric participants in the severe febrile 
illness social biopsy study, Tanzania, 2015–2016.
Characteristic Total (n=475) Cases (n=18)
Survivors 
(n=457) P value†
Matched on age and gender*
Controls (n=142) P value‡
Age (years) 2.2 (2.5)§ 1.8 (2.2)§ 2.2 (2.5)§ 0.524 1.9 (2.2)§ 0.791
Duration of illness at time of 
enrolment (days)
6.6 (5.2)§ 12.4 (13.0)§ 6.4 (4.5)§ <0.001 6.6 (5.1)§ <0.001
Gender
  Female 205 (43.2) 10 (55.6) 195 (42.7) 0.283 75 (52.8) 0.826
Admitting hospital
  KCMC 251 (52.8) 13 (72.2) 238 (52.1) 77 (54.2)
  MRRH 224 (47.2) 5 (27.8) 219 (47.9) 0.093 65 (45.8) 0.147
Tribe
  Chagga 232 (48.8) 6 (33.3) 226 (49.5) 57 (40.1)
  Pare 61 (12.8) 5 (27.8) 56 (12.3) 24 (16.9)
  Maasai 16 (3.4) 0 (0.0) 16 (3.5) 5 (3.5)
  Other 166 (34.9) 7 (38.9) 159 (34.8) 0.180 56 (39.4) 0.601
Education¶
  None 11 (2.3) 1 (5.6) 10 (2.2) 4 (2.8)
  Primary (1–7 years) 226 (47.8) 10 (55.6) 216 (47.5) 65 (46.1)
  Secondary (8–11 years) 152 (32.1) 6 (33.3) 146 (32.1) 53 (37.6)
  High school (12–13 years) 2 (0.4) 0 (0.0) 2 (0.4) 0 (0.0)
  University/college 82 (17.3) 1 (5.6) 81 (17.8) 0.616 19 (13.5) 0.670
Home region
  Kilimanjaro 427 (90.1) 14 (77.8) 413 (90.6) 130 (91.5)
  Other 47 (9.9) 4 (22.2) 43 (9.4) 0.075 12 (8.5) 0.067
Urban status**
  Urban 258 (64.7) 6 (46.2) 252 (65.3) 84 (69.4)
  Mixed 22 (5.5) 1 (7.7) 21 (5.4) 5 (4.1)
  Rural 119 (29.8) 6 (46.2) 113 (29.3) 0.363 32 (26.4) 0.236
Self-reported HIV status
  Positive 4 (0.8) 0 (0.0) 4 (0.9) 0.690 142 (100.0) 1.000
Recent hospitalisation (previous 
12 months)
  Yes 174 (36.6) 10 (55.6) 164 (35.9) 0.089 46 (32.4) 0.052
Has health insurance
  Yes 89 (18.7) 1 (5.6) 88 (19.3) 0.144 28 (19.7) 0.142
Severe symptoms on entering 
health system
  Lethargy 87 (18.3) 5 (27.8) 82 (17.9) 0.290 26 (18.3) 0.338
  Inability to drink 48 (10.1) 4 (22.2) 44 (9.6) 0.082 17 (12) 0.225
  Convulsions 79 (16.6) 6 (33.3) 73 (16) 0.052 23 (16.2) 0.075
  Vomiting 244 (51.5) 10 (55.6) 234 (51.3) 0.724 68 (47.9) 0.540
  Stiff neck 12 (2.5) 0 (0) 12 (2.6) 0.486 3 (2.1) 0.534
  Severe skin pustules†† 10 (4.9) 0 (0) 10 (5.1) 0.487 4 (6.1) 0.448
  Less movement†† 185 (89.8) 9 (100) 176 (89.3) 0.301 61 (92.4) 0.393
  Chest indrawing†† 35 (17.2) 5 (55.6) 30 (15.4) 0.002 11 (16.7) 0.008
  Pus draining from ear†† 1 (0.5) 0 (0) 1 (0.5) 0.830 1 (1.5) 0.710
Continued
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Transport delays
For paediatric participants, taking >1 hour to reach 
a healthcare facility at any point was associated with 
increased odds of death (OR: 3.27; 95% CI 1.11 to 9.66; 
AF: 27.0%; 95% CI 12.9% to 38.8%; table 3). Of the two 
transport delays (box 1), each additional delay present 
was associated with mortality (OR: 2.45; 95% CI 1.12 to 
5.33). Among adults, taking >1 hour to reach a facility 
at any point had an OR of 3.03 (95% CI 1.32 to 6.99; 
AF: 25.6%; 95% CI 14.3% to 35.5%) for mortality, and 
each additional transport delay was associated with 2.16 
increased odds of death (95% CI 1.07 to 4.36).
Healthcare system delays
Among paediatric participants, each additional health-
care facility visited was associated with increased 
mortality (OR: 1.59; 95% CI 1.06 to 2.38; table 4). Partic-
ipants spending >4 days between the first presentation 
to a healthcare facility and reaching tertiary care had 
increased odds of mortality (OR: 4.39; 95% CI 1.49 to 
12.93; AF 42.9%; 95% CI 27.4% to 55.1%). Analysed as a 
continuous variable, the number of days between the first 
presentation to a healthcare facility and reaching tertiary 
care was also associated with mortality (OR: 1.09; 95% CI 
1.02 to 1.17) per unit time in days.
Among adult participants, visiting >2 healthcare facili-
ties was associated with mortality (OR: 5.33; 95% CI 1.46 
to 19.41; AF: 34.5%; 95% CI 18.4% to 47.4%; table 4), as 
was spending >4 days between the first presentation to a 
healthcare facility and reaching tertiary care (OR: 3.15; 
95% CI 1.11 to 8.92; AF: 32.1%; 95% CI 14.7% to 46.0%). 
Analysed as a continuous variable, each additional health-
care facility visit was associated with 2.00 increased odds 
of death (95% CI 1.17 to 3.41).
Healthcare system pathway
Among paediatric participants, both cases and controls 
visited up to four healthcare facilities (figure 2A). Partic-
ipants not visiting a tertiary level facility within their first 
two facility visits had greater odds of death than those 
who did (OR: 2.88; 95% CI 1.01 to 8.20). Among adult 
participants, cases visited up to six healthcare facilities, 
whereas no controls visited >3 facilities (figure 2B). Not 
reaching tertiary level care within the first two facility 
visits was also associated with increased odds of mortality 
among adults (OR: 5.24; 95% CI 1.47 to 18.69).
sensitivity analysis
Among paediatric participants, 103 (59.5%) of those who 
were lost to follow-up had a caregiver with no more than 
primary school education, compared with 226 (47.8%) 
of those in the study cohort (P<0.001; online supple-
mentary table 2A). Of those paediatric participants lost 
to follow-up, five (2.9%) participants reported the child 
being HIV seropositive compared with four (0.8%) of 
those in the study cohort (P=0.049). Forty-four (25.4%) 
of the paediatric participants lost to follow-up had one or 
more prior hospitalisations in the previous 12 months, 
compared with 174 (36.6%) of those in the study cohort 
(P=0.008) and 16 (9.2%) of those lost to follow-up 
reported having health insurance, compared with 89 
(18.7%) of those in the study cohort (P=0.004).
Among adult participants, 8 (6.3%) of those lost to 
follow reported having a chronic comorbidity, compared 
with 46 (17.7%) of those in the study cohort (P=0.003; 
online supplementary table 2B).
In a sensitivity analysis of symptom-specific associations 
between delays and mortality, there were no significant 
associations between delays and mortality among paedi-
atric or adult participants for any of the severe symptom 
subsets (online supplementary table 3A and B).
dIsCussIon
We found that for patients admitted with febrile illness 
in northern Tanzania, delays at home, in transport and 
in the healthcare system were common. After controlling 
for age, gender and severity of illness, death was associ-
ated with delayed care-seeking and a lack of recognition 
of severe illness by adult participants or their caregivers. 
Characteristic Total (n=475) Cases (n=18)
Survivors 
(n=457) P value†
Matched on age and gender*
Controls (n=142) P value‡
 Nasal flaring†† 26 (12.7) 1 (11.1) 25 (12.8) 0.885 10 (15.2) 0.748
 Bulging fontanelle†† 4 (2) 0 (0) 4 (2) 0.665 1 (1.5) 0.710
 Grunting†† 25 (12.2) 1 (11.1) 24 (12.2) 0.919 8 (12.1) 0.930
Data are reported as n (%) unless otherwise indicated.
*9:1 nearest-neighbour matching with deduplication.
†P value is for the differences between cases and all survivors. P values are derived from t-test for means and χ2 tests for proportions.
‡P value is for the differences between cases and the given set of matched controls. P values are derived from t-test for means and χ2 tests 
for proportions.
§Data are reported as mean (SD).
¶Highest education level completed by the caregiver.
**Urban, mixed or rural were assigned at ward level and are based on classification from the 2012 census that defined urban as, ‘localities 
that are identified as urban areas by the district authority’. Mixed refers to wards containing both urban and rural villages.
††Only assessed for participants less than 1 year of age.
KCMC, Kilimanjaro Christian Medical Centre; MRRH, Mawenzi Regional Referral Hospital. 
Table 1A Continued 
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Table 1B Background characteristics and prevalence of severe symptoms for 260 adult participants in the severe febrile 
illness social biopsy study, Tanzania, 2015–2016.
Characteristic Total (n=260) Cases (n=34)
Survivors 
(n=226) P value‡
Matched on age and 
gender*
Matched on age, 
gender and severity of 
illness†
Controls 
(n=122)  P value§
Controls 
(n=47) P value§
Age (years) 40.3 (17.9)¶ 47.6 (20.4)¶ 39.2 (17.2)¶ 0.011 44.5 (18.2)¶ 0.402 43.1 (18.6)¶ 0.306
Duration of illness at 
time of enrolment (days)
9.6 (10.4)¶ 15.1 (16.0)¶ 8.8 (9.0)¶ 0.001 8.2 (7.8)¶ 0.001 9.7 (12.9)¶ 0.103
Gender
  Female 118 (45.9) 13 (38.2) 105 (47.1) 0.335 51 (41.8) 0.708 14 (29.8) 0.426
Admitting hospital
  KCMC 112 (43.1) 22 (64.7) 90 (39.8) 51 (41.8) 22 (46.8)
  MRRH 148 (56.9) 12 (35.3) 136 (60.2) 0.006 71 (58.2) 0.018 25 (53.2) 0.111
Tribe
  Chagga 136 (52.3) 17 (50) 119 (52.7) 71 (58.2) 23 (48.9)
  Pare 41 (15.8) 7 (20.6) 34 (15.0) 15 (12.3) 7 (14.9)
  Maasai 4 (1.5) 0 (0.0) 4 (1.8) 2 (1.6) 1 (2.1)
  Other 79 (30.4) 10 (29.4) 69 (30.5) 0.746 34 (27.9) 0.533 16 (34) 0.746
Education**
  None 7 (2.7) 1 (2.9) 6 (2.7) 3 (2.5) 1 (2.1)
  Primary (1–7 years) 159 (61.2) 23 (67.6) 136 (60.2) 82 (67.2) 29 (61.7)
  Secondary (8–
11 years)
57 (21.9) 9 (26.5) 48 (21.2) 18 (14.8) 9 (19.1)
  High school (12–
13 years)
6 (2.3) 0 (0.0) 6 (2.7) 4 (3.3) 3 (6.4)
  University/college 31 (11.9) 1 (2.9) 30 (13.3) 0.380 15 (12.3) 0.238 5 (10.6) 0.356
Home region
  Kilimanjaro 217 (83.5) 25 (73.5) 192 (85.0) 110 (90.2) 40 (85.1)
  Other 43 (16.5) 9 (26.5) 34 (15.0) 0.095 12 (9.8) 0.012 7 (14.9) 0.197
Urban status††
  Urban 104 (54.7) 6 (35.3) 98 (56.6) 55 (56.7) 21 (60.0)
  Mixed 6 (3.2) 1 (5.9) 5 (2.9) 1 (1.0) 0 (0.0)
  Rural 80 (42.1) 10 (58.8) 70 (40.5) 0.227 41 (42.3) 0.131 14 (40.0) 0.118
Self-reported HIV status
  Positive 42 (16.2) 6 (17.6) 36 (15.9) 0.800 20 (16.4) 0.862 7 (14.9) 0.739
Recent hospitalisation 
(previous 12 months)
  Yes 72 (27.7) 9 (26.5) 63 (27.9) 0.864 35 (28.7) 0.799 13 (27.7) 0.905
Has health insurance
  Yes 61 (23.6) 6 (17.6) 55 (24.4) 0.384 31 (25.6) 0.335 13 (27.7) 0.294
Marital status
  Married 160 (62.3) 23 (67.6) 137 (61.4) 0.486 88 (72.7) 0.562 30 (65.2) 0.820
Occupation
  Farmer 69 (26.5) 12 (35.3) 57 (25.2) 35 (28.7) 16 (34.0)
  Student 37 (14.2) 5 (14.7) 32 (14.2) 16 (13.1) 8 (17.0)
  Merchant 43 (16.5) 2 (5.9) 41 (18.1) 21 (17.2) 4 (8.5)
  Labourer 37 (14.2) 6 (17.6) 31 (13.7) 0.521 15 (12.3) 0.644 4 (8.5) 0.833
Continued
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Mortality was also higher among paediatric and adult 
participants who experienced delays in transport and 
delays in reaching tertiary level care. Presenting to 
multiple lower-level healthcare facilities was associated 
with increased odds of death and may be one reason for 
delayed presentations to tertiary-level care. The findings 
in this ‘social biopsy’ study suggest that community educa-
tion regarding severe symptom recognition, improved 
transport infrastructure and ensuring rapid referrals 
to tertiary level facilities may help prevent deaths from 
febrile illnesses.
Delays at home were associated with increased odds 
of mortality among adult but not paediatric partici-
pants. The distinction between the effects of paediatric 
and adult delays is important for two reasons. First, 
social autopsy studies have reported the importance of 
delays at home among fatal paediatric illness. A study in 
Uganda found that 42% of 174 fatal childhood illnesses 
had delayed seeking care for >24 hours after the onset 
of a severe symptom.12 In Ghana, it was shown that 50% 
of 264 severe childhood illness were not recognised as 
severe.34 However, we have demonstrated that delays at 
home were common in both fatal and non-fatal paedi-
atric febrile illnesses, yet they did not increase the odds 
of death and thus may not be the most important targets 
for intervention. Second, social autopsy studies have not 
focused on non-maternal adults. We found that delayed 
care-seeking due to a lack of severe illness recognition is 
associated with mortality among adults. This association 
suggests that >30% of febrile deaths among working-age 
adults might be prevented through education about the 
severe symptoms that should prompt care-seeking.
We found that a delay >1 hour in reaching a facility 
at any point during an illness increased the odds of 
mortality among paediatric and adult participants. 
Several social autopsy studies have found transport delays 
to be common.12 14 35–37 However, these studies only 
considered transport delays to the first or last facility. 
When we limited our analysis to the first or last facility, 
the association between >1 hour delay and mortality was 
not significant. We also found that each additional trans-
port delay was associated with increased odds of death. 
Thus, the association of transport delays with mortality 
was additive and delays in transport to facilities between 
the first and last were associated with mortality. An initial 
intervention may be to strengthen referral transporta-
tion infrastructure, which could be followed by commu-
nity ambulance services, which currently are unavailable 
Characteristic Total (n=260) Cases (n=34)
Survivors 
(n=226) P value‡
Matched on age and 
gender*
Matched on age, 
gender and severity of 
illness†
Controls 





  Yes 46 (17.7) 7 (20.6) 39 (17.3) 0.635 26 (21.3) 0.927 7 (14.9) 0.504
Severe symptoms 
present on entering the 
health system
 Weakness 55 (21.2) 18 (52.9) 37 (16.4) <0.001 11 (9) <0.001 19 (40.4) 0.264
 Difficulty breathing 43 (16.5) 9 (26.5) 34 (15) 0.095 7 (5.7) 0.026 12 (25.5) 0.924
 Confusion 11 (4.2) 5 (14.7) 6 (2.7) 0.001 3 (2.5) 0.316 3 (6.4) 0.215
 Lethargy 23 (8.8) 11 (32.4) 12 (5.3) <0.001 4 (3.3) <0.001 7 (14.9) 0.062
 Inability to drink 13 (5) 5 (14.7) 8 (3.5) 0.005 3 (2.5) 0.316 4 (8.5) 0.381
 Convulsions 2 (0.8) 0 (0) 2 (0.9) 0.582 2 (1.6) 0.452 1 (2.1) 0.392
 Stiff neck 9 (3.5) 2 (5.9) 7 (3.1) 0.408 1 (0.8) 0.057 2 (4.3) 0.739
 Abdominal pain 64 (24.6) 8 (23.5) 56 (24.8) 0.875 19 (15.6) 0.771 7 (14.9) 0.323
Data are reported as n (%) unless otherwise indicated.
*6:1 nearest-neighbour matching with deduplication.
†2:1 nearest-neighbour matching with deduplication.
‡P value is for the differences between cases and all survivors. P values are derived from t-test for means and χ2 tests for 
proportions.
§P value is for the differences between cases and the given set of matched controls. P values are derived from t-test for means and 
χ2 tests for proportions.
¶Data are reported as mean (SD).
**Highest education level completed by the patient.
††Urban, mixed or rural were assigned at ward level and are based on classification from the 2012 census that defined urban as, 
‘localities that are identified as urban areas by the district authority’. Mixed refers to wards containing both urban and rural villages.
KCMC, Kilimanjaro Christian Medical Centre; MRRH,  Mawenzi Regional Referral Hospital. 
Table 1B Continued 
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in northern Tanzania and have been associated with 
decreased mortality in other settings.38–40
By enrolling at the tertiary hospital level, our study 
was well suited to examine health system delays, which 
previous studies have often neglected in favour of 
analysing patient decision-making delays.41 We found 
that spending >4 days between the first facility presen-
tation and reaching tertiary care had an increased odds 
of mortality for both adult and paediatric participants. 
In fact, 42.9% of paediatric and 32.1% of adult febrile 
deaths may be attributable to taking >4 days to reach 
tertiary care. Furthermore, each additional facility visit 
increased the odds of death. A social autopsy study on 
fatal childhood pneumonia in Uganda showed that only 
22% of patients initially taken to a clinic were referred 
to a district hospital and that only 31% of those who 
reached a district hospital were referred to tertiary 
care.11 We identified similar delays in reaching referral or 
higher level care and demonstrated that such delays were 
associated with increased odds of mortality. Therefore, 
referring the sickest febrile patients directly to tertiary 
care may reduce the risk of death associated with febrile 
illness in Tanzania.
One limitation of our design was selection bias due 
to hospital-based enrolment. Patterns of delays among 
non-hospitalised febrile patients may differ from the 
patterns we identified in our study, and for this reason, 
our future work will include healthcare utilisation data 
from community members. There may have been addi-
tional selection bias from limiting our analysis to those 
participants who could be reached for follow-up. To 
assess this bias, we compared background characteristics 
between those lost to follow-up and those in the study 
cohort. The study cohort was more likely to report having 
health insurance, higher levels of education and at least 
one hospitalisation in the past 12 months. However, as 
one might expect delays to be more impactful among 
families with lower socioeconomic status, we speculate 
that our lost to follow-up bias would likely underestimate 
of the impact of delays, though we cannot conclusively 
infer the direction of bias. Also, while we used a robust 
matching process, this process introduced recall bias 
through participants’ listing of severe symptoms. Our 
matching process also did not control for HIV seropos-
itivity, as HIV status was self-reported and not laboratory 
confirmed. However, the prevalence of self-reported HIV 
seropositivity was balanced between cases and controls.
Our findings point to directions for future research 
and potential interventions. Future research may include 
characterising the determinants of the Three Delays 
that are associated with mortality, such as describing 
the explanatory models for illness among our patient 
population or studying the main areas of socioeconomic 
inequity in the community. Our results suggest interven-
tions in our catchment area could include programmes 
to improve illness recognition in the community such 
as training community health workers42 43 or teachers44 
to recognise severe illness. Improved interfacility or 
community ambulances may help counter delays in trans-
port. Our findings suggest at least two points of interven-
tion to minimise health system delays. The first would 
be ensuring that all Tanzanian healthcare personnel 
Figure 2 Pathway analysis comparing the pathways through the healthcare system between paediatric and adult cases and 
matched controls in the severe febrile illness social biopsy study, Tanzania, 2015–2016. Note: from left to right, the diagram 
depicts each subsequent healthcare facility encounter, such that participants who visited a higher number of facilities have 
pathways that extend further to the right. The numbers on each node represent the number of participants presenting to that 
facility and the proportion of total patients traveling to each facility type is reflected in the width of bars flowing from one facility 
to the next. An individual’s pathway ends when he or she reaches MRRH or KCMC represented by the red segments. Matching 
on severity of illness was done at the time of visiting the first facility, such that cases and controls are equally sick in column 
1 of the diagram. MRRH and KCMC were combined in the pathway diagram, as they both provide tertiary-level referral care 
and they represent the end of participants’ healthcare system pathways at the time of enrolment. MRRH,  Mawenzi Regional 
Referral Hospital; KCMC, Kilimanjaro Christian Medical Centre.
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at lower level healthcare facilities can recognise severe 
symptoms. The second would be strengthening referral 
pathways and developing explicit criteria for referral of 
severely ill febrile patients to tertiary care. Jointly these 
interventions may decrease mortality associated with 
febrile illness >30% in adult and >40% in paediatric 
patients who reach tertiary care during their illness.
In conclusion, we found that delays at home, in trans-
port and in the healthcare system were associated with 
increased odds of death from febrile illness in northern 
Tanzania. Our social biopsy approach effectively 
measured the association between delays and mortality 
and could be applied in other settings to identify socio-
cultural, behavioural and health system factors that 
contribute to fatal outcomes from febrile illnesses.
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